Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amy Paller

Pediatrics Chicago, IL Medical Doctor

NPI 1861452815 CMS profile 311623

2515 N Clark, Chicago, IL 60614

Open in the dashboard

General payments

$1,206,660

589 records reported · program years 2019–2025

Research payments

$342,849

Paid to them · 434 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,745,888 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Amy Paller of Chicago, IL is reported in the CMS Open Payments database as having received $1,206,660 across 589 general payments and $342,849 in research payments paid to them. Separately, studies naming them as principal investigator received $5,745,888 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $126,121 76
2025 Research $61,065 56
2024 General $150,573 83
2024 Research $59,361 68
2023 General $116,144 77
2023 Research $51,367 81
2022 General $193,291 86
2022 Research $54,204 75
2021 General $226,262 60
2021 Research $52,405 80
2020 General $226,057 101
2020 Research $25,390 30
2019 General $168,212 106
2019 Research $39,057 44

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Paller
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Amy Paller were reported at $126,121. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Amy Paller Pediatrics median Middle half National median
2019 $168,212 $86 $31–$183 $163
2020 $226,057 $49 $22–$110 $114
2021 $226,262 $68 $27–$158 $132
2022 $193,291 $77 $30–$173 $149
2023 $116,144 $88 $33–$190 $160
2024 $150,573 $94 $34–$206 $164
2025 $126,121 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $359,210 123 payments
  2. Sanofi-Aventis U.S. LLC $135,821 29 payments
  3. LEO Pharma AS $110,377 33 payments
  4. Eli Lilly and Company $82,640 81 payments
  5. Regeneron Pharmaceuticals, Inc. $80,105 48 payments
  6. LEO Pharma Inc. $52,716 14 payments
  7. AbbVie, Inc. $47,521 20 payments
  8. Boehringer Ingelheim International GmbH $42,926 26 payments
  9. Pfizer Inc. $42,516 18 payments
  10. E.R. Squibb & Sons, L.L.C. $24,195 9 payments
  11. Other $228,634 188 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $820,315 218 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $269,886 68 payments
  3. Travel and Lodging $77,050 122 payments
  4. Honoraria $30,729 7 payments
  5. Food and Beverage $6,327 170 payments
  6. Grant $2,323 2 payments
  7. Education $30 2 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $275,252 75 payments
  2. DUPIXENT Inflammation And Immunology $99,093 71 payments
  3. DUPIXENT Immunology $36,088 8 payments
  4. EBGLYSS $26,114 6 payments
  5. FILSUVEZ $16,551 10 payments
  6. COSENTYX $14,830 6 payments
  7. SKYRIZI $14,600 3 payments
  8. PROTOPIC $14,176 4 payments
  9. OPZELURA $11,268 8 payments
  10. VTAMA $10,022 7 payments
  11. Other $71,282 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $230,986 326 payments
  2. Genzyme Corporation $24,500 58 payments
  3. AbbVie, Inc. $20,318 20 payments
  4. Amgen Inc. $16,935 4 payments
  5. Pfizer Inc. $12,880 11 payments
  6. Eli Lilly and Company $9,274 3 payments
  7. Galderma Research & Development, LLC $8,550 5 payments
  8. LEO Pharma AS $7,466 2 payments
  9. Galderma Laboratories, L.P. $7,330 3 payments
  10. Celgene Corporation $4,010 1 payment

Records

1,023 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record